##4079996
The	the	at
study	study	nn1
examined	examine	vvd_vvn
associations	association	nn2
between	between	ii
hepatitis	hepatitis	nn1
C	c	zz1_np1
(	(	y
HCV	hcv	np1
)	)	y
seropositivity	seropositivity	nn1
and	and	cc
a	a	at1
lifetime	lifetime	nnt1
history	history	nn1
of	of	io
jail	jail	nn1
or	or	cc
correctional	correctional	jj
facility	facility	nn1
incarceration	incarceration	nn1
among	among	ii
injection	injection	nn1
drug	drug	nn1
users	user	nn2
.	.	y
The	the	at
sample	sample	nn1
consisted	consist	vvn_vvd
of	of	io
351	351	mc
injection	injection	nn1
drug	drug	nn1
users	user	nn2
recruited	recruit	vvn
in	in	ii
inner-city	inner-city	jj
neighborhoods	neighborhood	nn2
of	of	io
Baltimore	baltimore	np1
.	.	y
Multiple	multiple	jj
logistic	logistic	jj
regressions	regression	nn2
were	be	vbdr
fit	fit	jj
to	to	to
assess	assess	vvi
associations	association	nn2
between	between	ii
HCV	hcv	np1
seropositivity	seropositivity	nn1
and	and	cc
a	a	at1
lifetime	lifetime	nnt1
history	history	nn1
of	of	io
incarceration	incarceration	nn1
for	for	if
the	the	at
total	total	jj_nn1
sample	sample	nn1
and	and	cc
stratified	stratify	vvn
by	by	ii
race	race	nn1
.	.	y
Analyses	analysis	nn2
demonstrated	demonstrate	vvd_vvn
HCV	hcv	np1
nearly	nearly	rr
two	two	mc
times	time	nnt2
greater	great	jjr
for	for	if
whites	white	nn2
than	than	csn
African	african	jj
Americans	american	nn2
.	.	y
In	in	rr21
addition	addition	rr22
,	,	y
HCV	hcv	np1
was	be	vbdz
2.6	2.6	mc
times	time	nnt2
greater	great	jjr
in	in	ii
participants	participant	nn2
incarcerated	incarcerate	vvd_vvn@
in	in	ii_rp@
correctional	correctional	jj
facilities	facility	nn2
and	and	cc
HCV	hcv	np1
was	be	vbdz
7.4	7.4	mc
times	time	nnt2
greater	great	jjr
in	in	ii
participants	participant	nn2
reporting	report	vvg
more	more	dar
than	than	csn
5	5	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
compared	compare	vvn
to	to	ii
participants	participant	nn2
reporting	report	vvg
less	less	dar_rrr
than	than	csn
1	1	mc1
year	year	nnt1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
.	.	y
The	the	at
study	study	nn1
findings	finding	nn2
suggest	suggest	vv0
that	that	cst_dd1
incorporating	incorporate	vvg
systematic	systematic	jj
HCV	hcv	np1
screening	screening	nn1_vvg
,	,	y
prevention	prevention	nn1
,	,	y
and	and	cc
treatment	treatment	nn1
programs	program	nn2
within	within	ii
correctional	correctional	jj
systems	system	nn2
represents	represent	vvz
a	a	at1
vital	vital	jj
yet	yet	rr
under-utilized	under-utilize	vvn_jj@_vvd
strategy	strategy	nn1
to	to	to
reduce	reduce	vvi
HCV	hcv	np1
transmission	transmission	nn1
in	in	ii
society	society	nn1
as	as	ii
a	a	at1
whole	whole	nn1
.	.	y
In	in	ii
the	the	at
United	united	np1
States	state	np1
(	(	y
U.S.	us	np1
)	)	y
,	,	y
estimates	estimate	nn2_vvz
of	of	io
hepatitis	hepatitis	nn1
C	c	zz1_np1
virus	virus	nn1
(	(	y
HCV	hcv	np1
)	)	y
infection	infection	nn1
among	among	ii
the	the	at
general	general	jj_nn1
population	population	nn1
range	range	nn1
between	between	ii
2.7	2.7	mc
million	million	m1
and	and	cc
3.9	3.9	mc
million	million	m1
,	,	y
making	make	vvg
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
&;		null
Mast	mast	nn1
,	,	y
1994	1994	mc
)	)	y
.	.	y
A	a	at1
number	number	nn1
of	of	io
studies	study	nn2
have	have	vh0
identified	identify	vvn
drug-related	drug-related	nn1_jj
,	,	y
sexual	sexual	jj
,	,	y
and	and	cc
other	other	jj
drug-related	drug-related	jj_nn1
risk	risk	nn1
factors	factor	nn2
associated	associate	vvn
with	with	iw
HCV	hcv	np1
infection	infection	nn1
.	.	y
Risk	risk	vv0_nn1
factors	factor	nn2
deemed	deem	vvn
to	to	to
be	be	vbi
associated	associate	vvn
with	with	iw
HCV	hcv	np1
infection	infection	nn1
include	include	vv0
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
,	,	y
sexual	sexual	jj
contact	contact	nn1
with	with	iw
a	a	at1
steady	steady	jj
partner	partner	nn1
infected	infect	vvn_vvd
with	with	iw
HCV	hcv	np1
,	,	y
tattooing	tattoo	vvg
and	and	cc
ear	ear	nn1
piercing	piercing	nn1
,	,	y
intranasal	intranasal	jj
cocaine	cocaine	nn1
use	use	nn1_vv0
,	,	y
multiple	multiple	jj
sexual	sexual	jj
partners	partner	nn2
,	,	y
infants	infant	nn2
born	born	vvn
to	to	ii
infected	infected	jj
mothers	mother	nn2
,	,	y
organ	organ	nn1
transplantation	transplantation	nn1
and	and	cc
occupational	occupational	jj
exposure	exposure	nn1
to	to	ii
blood	blood	nn1
among	among	ii
health	health	nn1
care	care	nn1
workers	worker	nn2
(	(	y
Alter	alter	vv0
,	,	y
1997	1997	mc
;	;	y
Alter	alter	vv0
&;		null
Mast	mast	nn1
,	,	y
1994	1994	mc
;	;	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
,	,	y
2008	2008	mc
)	)	y
.	.	y
Furthermore	furthermore	rr
,	,	y
injection	injection	nn1
drug	drug	nn1
use	use	nn1
is	be	vbz
one	one	mc1
of	of	io
the	the	at
strongest	strong	jjt
risk	risk	nn1
factors	factor	nn2
for	for	if
HCV	hcv	np1
infection	infection	nn1
(	(	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
,	,	y
2008	2008	mc
)	)	y
.	.	y
Not	not	xx
surprisingly	surprisingly	rr
,	,	y
recent	recent	jj
studies	study	nn2
have	have	vh0
identified	identify	vvn
heightened	heightened	jj_vvd
HCV	hcv	np1
seropositivity	seropositivity	nn1
among	among	ii
incarcerated	incarcerated	jj@
populations	population	nn2
,	,	y
presumably	presumably	rr
as	as	csa
risk	risk	nn1
behaviors	behavior	nn2
associated	associate	vvn
with	with	iw
transmission	transmission	nn1
are	be	vbr
also	also	rr
associated	associate	vvn
with	with	iw
incarceration	incarceration	nn1
(	(	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
;	;	y
Macalino	macalino	np1
,	,	y
Vlahov	vlahov	np1
,	,	y
Dickinson	dickinson	np1
,	,	y
Schwartzapfel		np1
,	,	y
&;		null
Rich	rich	jj_np1@
,	,	y
2005	2005	mc
;	;	y
Solomon	solomon	np1
,	,	y
Flynn	flynn	np1
,	,	y
Muck	muck	nn1
,	,	y
&;		null
Vertefeuille	vertefeuille	np1
,	,	y
2004	2004	mc
)	)	y
.	.	y
Epidemiologic	epidemiologic	jj
studies	study	nn2
estimate	estimate	vv0
HCV	hcv	np1
prevalence	prevalence	nn1
among	among	ii
inmates	inmate	nn2
in	in	ii
the	the	at
United	united	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
al.	al	ra22
,	,	y
2004	2004	mc
;	;	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
Reindollar		np1
,	,	y
1999	1999	mc
;	;	y
Solomon	solomon	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
;	;	y
Vlahov	vlahov	np1
,	,	y
Nelson	nelson	np1
,	,	y
Quinn	quinn	np1
,	,	y
&;		null
Kendig	kendig	np1_vv0_nn1
,	,	y
1993	1993	mc
)	)	y
.	.	y
Additionally	additionally	rr
,	,	y
more	more	dar
than	than	csn
7	7	mc
million	million	m1
inmates	inmate	nn2
of	of	io
U.S.	us	np1
jails	jail	nn2
and	and	cc
correctional	correctional	jj
facilities	facility	nn2
are	be	vbr
released	release	vvn
annually	annually	rr
(	(	y
Hammett	hammett	np1
,	,	y
Harmon	harmon	np1_nn1
,	,	y
&;		null
Rhodes	rhodes	np1
,	,	y
2002	2002	mc
)	)	y
.	.	y
When	when	cs
considered	consider	vvn
in	in	ii31
light	light	ii32
of	of	ii33
the	the	at
substantial	substantial	jj
numbers	number	nn2
of	of	io
inmates	inmate	nn2
who	who	pnqs
are	be	vbr
returned	return	vvn
to	to	ii
society	society	nn1
each	each	dd1
year	year	nnt1
,	,	y
many	many	da2
of	of	io
whom	whom	pnqo
are	be	vbr
likely	likely	jj
to	to	to
be	be	vbi
infected	infect	vvn
with	with	iw
HCV	hcv	np1
,	,	y
the	the	at
social	social	jj
and	and	cc
economic	economic	jj
costs	cost	nn2
associated	associate	vvn
with	with	iw
the	the	at
continued	continued	jj
absence	absence	nn1
of	of	io
systematic	systematic	jj
HCV	hcv	np1
screening	screening	nn1_vvg
,	,	y
prevention	prevention	nn1
,	,	y
and	and	cc
treatment	treatment	nn1
efforts	effort	nn2
in	in	ii
correctional	correctional	jj
settings	setting	nn2
is	be	vbz
evident	evident	jj
.	.	y
While	while	cs
there	there	ex
is	be	vbz
a	a	at1
growing	growing	jj
base	base	nn1
of	of	io
research	research	nn1
describing	describe	vvg
heightened	heightened	jj
HCV	hcv	np1
prevalence	prevalence	nn1
among	among	ii
incarcerated	incarcerated	jj@
populations	population	nn2
,	,	y
few	few	da2
studies	study	nn2
have	have	vh0
examined	examine	vvn
associations	association	nn2
between	between	ii
HCV	hcv	np1
infection	infection	nn1
and	and	cc
incarceration	incarceration	nn1
among	among	ii
drug	drug	nn1
using	use	vvg
populations	population	nn2
.	.	y
For	for	rex21
example	example	rex22
,	,	y
extant	extant	jj
research	research	nn1
has	have	vhz
not	not	xx
evaluated	evaluate	vvn
the	the	at
extent	extent	nn1
to	to	ii
which	which	ddq
differing	differing	jj
levels	level	nn2
of	of	io
incarceration	incarceration	nn1
,	,	y
such	such	ii21
as	as	ii22
short-term	short-term	jj
jail	jail	nn1
stays	stay	vvz_nn2
versus	versus	ii
longer-term	longer-term	jj
incarceration	incarceration	nn1
in	in	ii
correctional	correctional	jj
facilities	facility	nn2
and	and	cc
prisons	prison	nn2
,	,	y
are	be	vbr
associated	associate	vvn
with	with	iw
variations	variation	nn2
in	in	ii
HCV	hcv	np1
prevalence	prevalence	nn1
.	.	y
Such	such	da
information	information	nn1
may	may	vm
help	help	vvi
to	to	to
improve	improve	vvi
efforts	effort	nn2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
within	within	ii
correctional	correctional	jj
systems	system	nn2
.	.	y
A	a	at1_zz1
related	related	jj
gap	gap	nn1
in	in	ii
the	the	at
literature	literature	nn1
concerns	concern	vvz
racial/ethnic	racial/ethnic	jj
differences	difference	nn2
in	in	ii
HCV	hcv	np1
prevalence	prevalence	nn1
.	.	y
General	general	jj_nn1
population	population	nn1
studies	study	nn2
have	have	vh0
shown	show	vvn
HCV	hcv	np1
prevalence	prevalence	nn1
among	among	ii
African	african	jj
Americans	american	nn2
to	to	to
be	be	vbi
higher	high	jjr
than	than	csn
that	that	dd1
of	of	io
whites	white	nn2
(	(	y
Fleckenstein	fleckenstein	np1
,	,	y
2004	2004	mc
;	;	y
Pyrsopoulos		np2
&;		null
Jeffers	jeffers	np1
,	,	y
2007	2007	mc
;	;	y
Rawls	rawls	np1
&;		null
Vega	vega	np1
,	,	y
2005	2005	mc
)	)	y
.	.	y
However	however	rr
,	,	y
three	three	mc
studies	study	nn2
conducted	conduct	vvn_vvd
with	with	iw
inmates	inmate	nn2
in	in	ii
Texas	texas	np1
(	(	y
Baillargeon	baillargeon	np1
et	et	ra21
al.	al	ra22
,	,	y
2003	2003	mc
)	)	y
,	,	y
Maryland	maryland	np1
(	(	y
Solomon	solomon	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
)	)	y
,	,	y
and	and	cc
California	california	np1
(	(	y
Ruiz	ruiz	np1
et	et	ra21
al.	al	ra22
,	,	y
1999	1999	mc
)	)	y
,	,	y
each	each	dd1
found	find	vvd
HCV	hcv	np1
prevalence	prevalence	nn1
to	to	to
be	be	vbi
highest	high	jjt_rrt@
among	among	ii
whites	white	nn2
.	.	y
It	it	pph1
is	be	vbz
important	important	jj
to	to	to
delineate	delineate	vvi
whether	whether	csw
and	and	cc
why	why	rrq
racial	racial	jj
differences	difference	nn2
in	in	ii
HCV	hcv	np1
exist	exist	vv0
for	for	if
incarcerated	incarcerated	jj@
populations	population	nn2
in	in	bcl21
order	order	bcl22
to	to	to
develop	develop	vvi
suitable	suitable	jj
prevention	prevention	nn1
and	and	cc
treatment	treatment	nn1
programs	program	nn2
for	for	if
vulnerable	vulnerable	jj
sub-populations	subpopulation	nn2
.	.	y
Higher	high	jjr
rates	rate	nn2
of	of	io
disease	disease	nn1
among	among	ii
specific	specific	jj
subgroups	subgroup	nn2
(	(	y
e.g.	eg	rex
,	,	y
racial	racial	jj
)	)	y
may	may	vm
result	result	vvi
in	in	ii
differences	difference	nn2
in	in	ii
risk	risk	nn1
behaviors	behavior	nn2
(	(	y
e.g.	eg	rex
,	,	y
needle	needle	nn1
and	and	cc
works	works	nn_vvz
sharing	share	vvg
)	)	y
in	in	ii
which	which	ddq
they	they	pphs2
engage	engage	vv0
and	and	cc
need	need	vv0_nn1
to	to	to
be	be	vbi
targeted	target	vvn
.	.	y
This	this	dd1
study	study	nn1
initially	initially	rr
examined	examine	vvn_vvd_jj@
associations	association	nn2
between	between	ii
HCV	hcv	np1
prevalence	prevalence	nn1
,	,	y
racial/ethnic	racial/ethnic	jj
status	status	nn1
,	,	y
and	and	cc
incarceration	incarceration	nn1
history	history	nn1
among	among	ii
injection	injection	nn1
drug	drug	nn1
users	user	nn2
.	.	y
Secondly	secondly	rr
,	,	y
we	we	ppis2
sought	seek	vvd
to	to	to
examine	examine	vvi
whether	whether	csw
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
African	african	jj
American	american	jj_nn1@
and	and	cc
white	white	jj
injection	injection	nn1
drug	drug	nn1
users	user	nn2
.	.	y
METHODS	method	nn2
The	the	at
present	present	jj_nn1
study	study	nn1
sample	sample	nn1
was	be	vbdz
collected	collect	vvn
as	as	ii
part	part	nn1
of	of	io
the	the	at
U.S.	us	np1
site	site	nn1
of	of	io
the	the	at
NEURO-HIV		np1
Epidemiologic	epidemiologic	jj
Study	study	nn1
,	,	y
an	a	at1
epidemiological	epidemiological	jj
examination	examination	nn1
of	of	io
neuropsychological	neuropsychological	jj
,	,	y
social	social	jj
,	,	y
and	and	cc
behavioral	behavioral	jj_nn1
risk	risk	nn1
factors	factor	nn2
of	of	io
HIV	hiv	np1
,	,	y
and	and	cc
hepatitis	hepatitis	nn1
A	a	zz1
,	,	y
B	b	zz1
,	,	y
and	and	cc
C	c	zz1_np1
among	among	ii
injection	injection	nn1
and	and	cc
non-injection	non-injection	jj_nn1
drug	drug	nn1
users	user	nn2
with	with	iw
sites	site	nn2
in	in	ii
the	the	at
U.S.	us	np1
,	,	y
South	south	np1
Africa	africa	np1
,	,	y
and	and	cc
Russia	russia	np1
.	.	y
To	to	to
be	be	vbi
eligible	eligible	jj
for	for	if
the	the	at
study	study	nn1
,	,	y
participants	participant	nn2
had	have	vhd
to	to	to
report	report	vvi
using	use	vvg
injection	injection	nn1
or	or	cc
non-injection	non-injection	jj_nn1
drugs	drug	nn2
during	during	ii
the	the	at
previous	previous	jj
6	6	mc
months	month	nnt2
,	,	y
and	and	cc
be	be	vbi
aged	age	vvn
15-50	15-50	mcmc
years	year	nnt2
.	.	y
Non-injection	non-injection	jj_nn1
drug	drug	nn1
users	user	nn2
were	be	vbdr
not	not	xx
included	include	vvn
in	in	ii
the	the	at
present	present	jj_nn1
study	study	nn1
,	,	y
because	because	cs
HCV	hcv	np1
seroprevalence	seroprevalence	nn1
in	in	ii
this	this	dd1
population	population	nn1
was	be	vbdz
low	low	jj
.	.	y
Because	because	cs
we	we	ppis2
sought	seek	vvd
to	to	to
examine	examine	vvi
associations	association	nn2
between	between	ii
HCV	hcv	np1
seropositivity	seropositivity	nn1
and	and	cc
incarceration	incarceration	nn1
status	status	nn1
stratified	stratify	vvn
by	by	ii
race/ethnicity	race/ethnicity	nn1
,	,	y
the	the	at
present	present	jj_nn1
study	study	nn1
sample	sample	nn1
was	be	vbdz
limited	limit	vvn
to	to	ii
African	african	jj
American	american	jj_nn1@
and	and	cc
white	white	jj
participants	participant	nn2
and	and	cc
did	do	vdd
not	not	xx
include	include	vvi
subjects	subject	nn2
of	of	io
Hispanic	hispanic	jj
,	,	y
Asian	asian	jj_nn1@
,	,	y
Native	native	jj
American	american	jj_nn1@
,	,	y
or	or	cc
mixed	mixed	jj@_vvd_vvn
race	race	nn1
ethnicities	ethnicity	nn2
(	(	y
n	xx_n	zz1
=	=	fo
18	18	mc
)	)	y
.	.	y
The	the	at
resulting	resulting	jj
study	study	nn1
sample	sample	nn1
of	of	io
351	351	mc
injection	injection	nn1
drug	drug	nn1
users	user	nn2
was	be	vbdz
comprised	comprise	vvn
of	of	io
African	african	jj
American	american	nn1@_jj
(	(	y
n	xx_n	zz1
=	=	fo
136	136	mc
;	;	y
38.8%	38.8%	fo
)	)	y
and	and	cc
white	white	jj_nn1@
(	(	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
n	xx_n	zz1
=	=	fo
212	212	mc
)	)	y
of	of	io
the	the	at
sample	sample	nn1
being	be	vbg
male	male	jj_nn1
.	.	y
Further	far	rrr
summarizes	summarize	vvz
of	of	io
sample	sample	nn1
characteristics	characteristic	nn2
are	be	vbr
presented	present	vvn
in	in	ii
Table	table	nn1
1	1	mc1
.	.	y
Full	full	jj
approval	approval	nn1
of	of	io
the	the	at
study	study	nn1
protocol	protocol	nn1
by	by	ii
the	the	at
Johns	john	np1
Hopkins	hopkins	np1
Bloomberg	bloomberg	np1
School	school	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
Institutional	institutional	jj
Review	review	nn1
Board	board	nn1
in	in	ii
2001	2001	mc
has	have	vhz
since	since	rr@
received	receive	vvn
annual	annual	jj
reviews	review	nn2
and	and	cc
approval	approval	nn1
.	.	y
Expert	expert	nn1_jj@
clinicians	clinician	nn2
who	who	pnqs
underwent	undergo	vvd
extensive	extensive	jj
training	training	nn1
,	,	y
including	including	ii_vvg@
formal	formal	jj
course	course	nn1
work	work	nn1_vv0
in	in	ii
HIV	hiv	np1
epidemiology	epidemiology	nn1
and	and	cc
prevention	prevention	nn1
,	,	y
seminars	seminar	nn2
on	on	ii
psycho-diagnostic	psycho-diagnostic	jj
and	and	cc
neuropsychological	neuropsychological	jj
assessment	assessment	nn1
,	,	y
and	and	cc
weekly	weekly	jj
team	team	nn1
meetings	meeting	nn2
and	and	cc
supervision	supervision	nn1
,	,	y
conducted	conduct	vvd_vvn
all	all	db
participant	participant	nn1
interviews	interview	nn2
and	and	cc
counseling	counseling	nn1
sessions	session	nnt2
.	.	y
PARTICIPANT	participant	nn1
SAMPLE	sample	nn1
SELECTION	selection	nn1
Enrollment	enrollment	nn1_np1
included	include	vvd_vvn
multiple	multiple	jj
recruitment	recruitment	nn1
strategies	strategy	nn2
,	,	y
such	such	ii21
as	as	ii22
street	street	nn1
outreach	outreach	nn1_vv0
,	,	y
advertisements	advertisement	nn2
in	in	ii
local	local	jj
newspapers	newspaper	nn2
,	,	y
outreach	outreach	vv0_nn1
at	at	ii
local	local	jj
needle	needle	nn1
exchange	exchange	nn1
sites	site	nn2
,	,	y
as	as	ii31
well	well	ii32
as	as	ii33
referrals	referral	nn2
from	from	ii
enrolled	enrolled	jj@
participants	participant	nn2
,	,	y
and	and	cc
social	social	jj
service	service	nn1
agencies	agency	nn2
.	.	y
Informed	informed	jj@_vvn
consent	consent	nn1
obtained	obtain	vvn_vvd
at	at	ii
the	the	at
outset	outset	nn1
of	of	io
the	the	at
baseline	baseline	nn1
assessment	assessment	nn1
also	also	rr
addressed	address	vvn_jj@_vvd
permission	permission	nn1
for	for	if
follow-up	follow-up	jj_nn1
contacts	contact	nn2
.	.	y
Participant	participant	nn1
incentives	incentive	nn2
included	include	vvd_vvn
$45	$45	nnu
for	for	if
the	the	at
baseline	baseline	nn1
assessment	assessment	nn1
,	,	y
$10	$10	nnu
for	for	if
locator	locator	nn1
visits	visit	nn2
,	,	y
and	and	cc
$55	$55	nnu
for	for	if
follow-up	follow-up	jj_nn1
assessments	assessment	nn2
.	.	y
DATA	data	nn
COLLECTION	collection	nn1
The	the	at
baseline	baseline	nn1
assessment	assessment	nn1
was	be	vbdz
comprised	comprise	vvn
of	of	io
a	a	at1
standardized	standardized	jj
face-to-face	face-to-face	jj
HIV-Risk	hiv-risk	jj_nn1
Behavior	behavior	nn1_np1
Interview	interview	nn1
,	,	y
a	a	at1
battery	battery	nn1
of	of	io
neuropsychological	neuropsychological	jj
tests	test	nn2
focusing	focus	vvg
mainly	mainly	rr
on	on	ii
executive	executive	nn1_jj@
functions	function	nn2
,	,	y
attention	attention	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
and	and	cc
urine	urine	nn1
sample	sample	nn1
collection	collection	nn1
.	.	y
Tests	test	nn2
of	of	io
HIV	hiv	np1
,	,	y
hepatitis	hepatitis	nn1
A	a	zz1
,	,	y
hepatitis	hepatitis	nn1
B	b	zz1
,	,	y
and	and	cc
hepatitis	hepatitis	nn1
C	c	zz1
used	used	jj
blood	blood	nn1
samples	sample	nn2
drawn	draw	vvn
by	by	ii
expert	expert	nn1_jj@
phlebotomists	phlebotomists	nn2
.	.	y
Urinalysis	urinalysis	np1@_nn1
tested	test	vvd
for	for	if
recent	recent	jj
use	use	nn1
of	of	io
cannabinoids	cannabinoids	nn2
,	,	y
opiates	opiate	nn2_vvz
,	,	y
cocaine	cocaine	nn1
,	,	y
amphetamine	amphetamine	vv0_nn1
,	,	y
methamphetamine	methamphetamine	vv0_nn1
,	,	y
methadone	methadone	vv0_nn1
,	,	y
PCP	pcp	np1
,	,	y
barbiturates	barbiturate	nn2
,	,	y
benzodiazepines	benzodiazepine	nn2_vvz
,	,	y
tricyclic	tricyclic	jj
antidepressants	anti-depressant	nn2
,	,	y
MDMA	mdma	np1_nn1
,	,	y
and	and	cc
oxycodone	oxycodone	nn1_vv0
.	.	y
Risk-reduction	risk-reduction	jj_nn1
counseling	counseling	nn1
provided	provide	vvn_vvd
to	to	ii
participants	participant	nn2
was	be	vbdz
pertinent	pertinent	jj
to	to	ii
HIV/AIDS	hiv/aids	fu
,	,	y
viral	viral	jj
hepatitis	hepatitis	nn1
,	,	y
and	and	cc
other	other	jj
STDs	std	nn2
as	as	ii31
well	well	ii32
as	as	ii33
referral	referral	nn1
information	information	nn1
to	to	ii
community-based	community-based	jj_nn1
drug	drug	nn1
treatment	treatment	nn1
and	and	cc
social	social	jj
services	service	nn2
.	.	y
MEASURES	measure	nn2_vvz@
The	the	at
HIV-Risk	hiv-risk	jj_nn1
Behavior	behavior	nn1
Interview	interview	nn1
was	be	vbdz
originally	originally	rr
adapted	adapt	vvn_vvd
from	from	ii
a	a	at1
similar	similar	jj
interview	interview	nn1
used	use	vvn_vvd
for	for	if
the	the	at
REACH	reach	nn1
study	study	nn1
.	.	y
The	the	at
interview	interview	nn1
consisted	consist	vvn_vvd
of	of	io
questions	question	nn2
on	on	ii
demographics	demographics	nn2_nn1
and	and	cc
medical	medical	jj
,	,	y
educational	educational	jj
,	,	y
and	and	cc
neurodevelopment	neurodevelopment	nn1
histories	history	nn2
,	,	y
including	including	ii_vvg@
STDs	std	nn2
and	and	cc
detailed	detailed	jj
behavioral	behavioral	jj_nn1
information	information	nn1
about	about	ii
drug	drug	nn1
use	use	nn1_vv0
,	,	y
sexual	sexual	jj
practices	practice	nn2
,	,	y
social	social	jj
networks	network	nn2
,	,	y
and	and	cc
community	community	nn1
violence	violence	nn1
(	(	y
Strathdee	strathdee	np1
&;		null
Sherman	sherman	np1
,	,	y
2003	2003	mc
)	)	y
.	.	y
Demographic	demographic	jj
variables	variable	nn2
collected	collect	vvn_vvd
via	via	ii
self-report	self-report	nn1_jj
included	include	vvd_vvn_jj%
gender	gender	nn1
,	,	y
age	age	nn1_vv0@
,	,	y
education	education	nn1
,	,	y
and	and	cc
race	race	nn1
.	.	y
Participants	participant	nn2
self-reported	self-reported	nn1_jj
their	their	appge
race/ethnicity	race/ethnicity	nn1
and	and	cc
were	be	vbdr
categorized	categorize	vvn@
as	as	csa_rg@_ii@
African	african	jj
American	american	jj_nn1@
;	;	y
Asian	asian	jj
or	or	cc
Pacific	pacific	np1
Islander	islander	np1_nn1
;	;	y
Hispanic	hispanic	jj
or	or	cc
Latino	latino	np1_nn1
;	;	y
Native	native	jj
American	american	jj_nn1@
;	;	y
White	white	np1_jj
;	;	y
or	or	cc
multiple	multiple	jj
racial	racial	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
had	have	vhd
some	some	dd
high	high	jj
school	school	nn1
,	,	y
a	a	at1
general	general	jj_nn1
equivalency	equivalency	nn1
degree	degree	nn1
(	(	y
GED	ged	np1
)	)	y
,	,	y
a	a	at1
high	high	jj
school	school	nn1
diploma	diploma	nn1
,	,	y
or	or	cc
some	some	dd
college	college	nn1
experience	experience	nn1
,	,	y
with	with	iw
participants	participant	nn2
having	have	vhg
no	no	at
high	high	jj
school	school	nn1
education	education	nn1
as	as	ii_csa
the	the	at
referent	referent	jj_nn1
group	group	nn1
.	.	y
The	the	at
interview	interview	nn1
obtained	obtain	vvd_vvn
data	data	nn
on	on	ii
lifetime	lifetime	nnt1
incarceration	incarceration	nn1
status	status	nn1
,	,	y
distinguishing	distinguish	vvg
between	between	ii
jail	jail	nn1
incarceration	incarceration	nn1
and	and	cc
incarceration	incarceration	nn1
in	in	ii
correctional	correctional	jj
facilities	facility	nn2
or	or	cc
prisons	prison	nn2
.	.	y
Typically	typically	rr
,	,	y
the	the	at
length	length	nn1
of	of	io
a	a	at1
jail	jail	nn1
stay	stay	vv0_nn1@
in	in	ii
Maryland	maryland	np1
during	during	ii
the	the	at
study	study	nn1
period	period	nn1
was	be	vbdz
between	between	ii
one	one	mc1
and	and	cc
30	30	mc
days	day	nnt2
,	,	y
while	while	cs
the	the	at
length	length	nn1
of	of	io
stay	stay	nn1@_vv0
in	in	ii
a	a	at1
correctional	correctional	jj
facility	facility	nn1
or	or	cc
prison	prison	nn1
was	be	vbdz
typically	typically	rr
for	for	if
a	a	at1
period	period	nn1
of	of	io
months	month	nnt2
or	or	cc
longer	long	rrr_jjr
.	.	y
Further	far	jjr
variables	variable	nn2
of	of	io
interest	interest	nn1
included	include	vvd_vvn
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
,	,	y
which	which	ddq
was	be	vbdz
also	also	rr
collected	collect	vvn_vvd
via	via	ii
self-report	self-report	nn1_jj
.	.	y
Participants	participant	nn2
were	be	vbdr
grouped	group	vvn
into	into	ii
3	3	mc
categories	category	nn2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
duration	duration	nn1
:	:	y
less	less	dar_rrr
than	than	csn
1	1	mc1
year	year	nnt1
of	of	io
use	use	nn1
,	,	y
1-5	1-5	mcmc
years	year	nnt2
and	and	cc
greater	great	jjr
than	than	csn
5	5	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
(	(	y
Galeazzi	galeazzi	np1_nn1
,	,	y
Tufano	tufano	np1_nn1
,	,	y
Barbierato		np1_nn1
,	,	y
&;		null
Bortolotti	bortolotti	np1_nn1
,	,	y
1995	1995	mc
;	;	y
Garfein	garfein	np1
,	,	y
Vlahov	vlahov	np1
,	,	y
Galai	galai	np1_nn1
,	,	y
Doherty	doherty	np1_nn1
,	,	y
&;		null
Nelson	nelson	np1
,	,	y
1996	1996	mc
;	;	y
Hagan	hagan	np1
et	et	ra21
al.	al	ra22
,	,	y
2007	2007	mc
)	)	y
.	.	y
HCV	hcv	np1
ANTIBODY	antibody	np1_nn1
TESTING	testing	nn1_vvg_np1@
Tests	test	nn2
of	of	io
blood	blood	nn1
specimens	specimen	nn2
used	use	vvd_vvn_jj
Ortho-Clinical	ortho-clinical	jj
Diagnostics	diagnostics	nn1
Inc	inc	jj
.	.	y
HCV	hcv	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
for	for	if
the	the	at
detection	detection	nn1
of	of	io
antibodies	antibody	nn2
to	to	ii
hepatitis	hepatitis	nn1
C	c	zz1_np1
Virus	virus	nn1
(	(	y
Anti-HCV	anti-hcv	jj
)	)	y
in	in	ii
human	human	jj_nn1
serum	serum	nn1
and	and	cc
plasma	plasma	nn1
samples	sample	nn2
.	.	y
The	the	at
Ortho	ortho	np1_nn1
HCV	hcv	np1
V	xx_v	zz1_ii@
3.0	3.0	mc
ELISA	elisa	np1
Test	test	nn1_vv0
System	system	nn1
used	use	vvd_jj_vvn
recombinant	recombinant	jj_nn1
antigens	antigen	nn2
provided	provide	vvn
by	by	ii
Chiron	chiron	np1_nn1
Corporation	corporation	nn1
.	.	y
STATISTICAL	statistical	jj
METHODS	method	nn2
Statistical	statistical	jj
analysis	analysis	nn1
included	include	vvd_vvn
the	the	at
sample	sample	nn1
of	of	io
351	351	mc
injection	injection	nn1
drug	drug	nn1
users	user	nn2
who	who	pnqs
reported	report	vvd
African	african	jj
American	american	jj_nn1@
or	or	cc
white	white	jj
racial/ethnic	racial/ethnic	jj
status	status	nn1
.	.	y
Initially	initially	rr
,	,	y
the	the	at
association	association	nn1
between	between	ii
HCV	hcv	np1
seropositivity	seropositivity	nn1
,	,	y
sociodemographic	sociodemographic	jj
,	,	y
injection	injection	nn1
drug	drug	nn1
duration	duration	nn1
and	and	cc
incarceration	incarceration	nn1
status	status	nn1
variables	variable	nn2
was	be	vbdz
evaluated	evaluate	vvn
using	use	vvg
the	the	at
total	total	jj_nn1
sample	sample	nn1
.	.	y
Use	use	nn1_vv0
of	of	io
descriptive	descriptive	jj
statistics	statistics	nn
identified	identify	vvn_vvd@_jj%
proportions	proportion	nn2
of	of	io
the	the	at
sample	sample	nn1
that	that	cst
tested	test	vvd
positive	positive	jj
for	for	if
HCV	hcv	np1
across	across	ii
the	the	at
levels	level	nn2
of	of	io
each	each	dd1
sociodemographic	sociodemographic	jj
and	and	cc
incarceration	incarceration	nn1
status	status	nn1
variable	variable	nn1
.	.	y
Analyses	analysis	nn2
of	of	io
associations	association	nn2
included	include	vvd_vvn
comparisons	comparison	nn2
of	of	io
participants	participant	nn2
reporting	report	vvg
a	a	at1
lifetime	lifetime	nnt1
history	history	nn1
of	of	io
jail	jail	nn1
incarceration	incarceration	nn1
only	only	rr
,	,	y
participants	participant	nn2
reporting	report	vvg
a	a	at1
history	history	nn1
of	of	io
correctional	correctional	jj
facility/prison	facility/prison	nn1
incarceration	incarceration	nn1
and	and	cc
participants	participant	nn2
reporting	report	vvg
no	no	at
history	history	nn1
of	of	io
incarceration	incarceration	nn1
using	use	vvg
simple	simple	jj
logistic	logistic	jj
regressions	regression	nn2
to	to	to
compute	compute	vvi
unadjusted	unadjusted	jj
odds	odds	nn2
ratios	ratio	nn2
.	.	y
Multiple	multiple	jj
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
were	be	vbdr
subsequently	subsequently	rr
fit	fit	vv0_jj
to	to	to
assess	assess	vvi
associations	association	nn2
between	between	ii
HCV	hcv	np1
seropositivity	seropositivity	nn1
,	,	y
race/ethnic	race/ethnic	fu
status	status	nn1
,	,	y
and	and	cc
incarceration	incarceration	nn1
status	status	nn1
with	with	iw
adjustment	adjustment	nn1
for	for	if
gender	gender	nn1
,	,	y
age	age	nn1_vv0@
,	,	y
education	education	nn1
and	and	cc
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
.	.	y
Further	far	rrr_jjr
,	,	y
a	a	at1
race/ethnicity	race/ethnicity	nn1
stratified	stratified	jj_vvn
analysis	analysis	nn1
examined	examine	vvd_vvn
simple	simple	jj
and	and	cc
multiple	multiple	jj_nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
and	and	cc
white	white	jj
participants	participant	nn2
,	,	y
separately	separately	rr
.	.	y
All	all	db_rr@
statistical	statistical	jj
analyses	analysis	nn2
were	be	vbdr
computed	compute	vvn
using	use	vvg
SAS	sa	np1
version	version	nn1
9.1	9.1	mc
(	(	y
SAS	sa	np1
9.1	9.1	mc
2002-2003	2002-2003	mcmc
)	)	y
.	.	y
RESULTS	result	nn2
Sixty-nine	sixty-nine	mc
percent	percent	nnu
of	of	io
the	the	at
sample	sample	nn1
was	be	vbdz
positive	positive	jj
for	for	if
HCV	hcv	np1
(	(	y
n	xx_n	zz1
=	=	fo
243	243	mc
)	)	y
.	.	y
Eighteen	eighteen	mc
percent	percent	nnu
(	(	y
n	xx_n	zz1
=	=	fo
64	64	mc
)	)	y
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
no	no	at
lifetime	lifetime	nnt1
history	history	nn1
of	of	io
any	any	dd
incarceration	incarceration	nn1
,	,	y
49%	49%	nnu
(	(	y
n	xx_n	zz1
=	=	fo
172	172	mc
)	)	y
reported	report	vvd_jj@
jail	jail	nn1
incarceration	incarceration	nn1
in	in	ii
their	their	appge
lifetime	lifetime	nnt1
,	,	y
and	and	cc
33%	33%	nnu
(	(	y
n	xx_n	zz1
=	=	fo
115	115	mc
)	)	y
reported	report	vvd
correctional	correctional	jj
facility	facility	nn1
incarceration	incarceration	nn1
in	in	ii
their	their	appge
lifetime	lifetime	nnt1
.	.	y
Among	among	ii
the	the	at
115	115	mc
participants	participant	nn2
reporting	report	vvg
correctional	correctional	jj
facility	facility	nn1
incarceration	incarceration	nn1
in	in	ii
their	their	appge
lifetime	lifetime	nnt1
,	,	y
92%	92%	nnu
(	(	y
n	xx_n	zz1
=	=	fo
106	106	mc
)	)	y
also	also	rr
reported	report	vvn_vvd
a	a	at1
history	history	nn1
of	of	io
jail	jail	nn1
incarceration	incarceration	nn1
.	.	y
All	all	db
participants	participant	nn2
reported	report	vvd_vvn
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
,	,	y
with	with	iw
55%	55%	nnu
(	(	y
n	xx_n	zz1
=	=	fo
192	192	mc
)	)	y
of	of	io
the	the	at
sample	sample	nn1
reporting	reporting	nn1
greater-than	greater-than	csn
5	5	mc
years	year	nnt2
of	of	io
use	use	nn1
.	.	y
Seventy-six	seventy-six	mc
percent	percent	nnu
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
that	that	dd1_cst
heroin	heroin	nn1
by	by	ii
itself	itself	ppx1
was	be	vbdz
their	their	appge
drug	drug	nn1
of	of	io
choice	choice	nn1
,	,	y
while	while	cs
9%	9%	nnu
reported	reported	jj@_vvn_vvd
speedball	speedball	nn1
,	,	y
and	and	cc
6%	6%	nnu
reported	reported	jj@_vvn_vvd
cocaine	cocaine	nn1
by	by	ii
itself	itself	ppx1
as	as	csa_ii@
their	their	appge
drug	drug	nn1
of	of	io
choice	choice	nn1
.	.	y
Ninety-seven	ninety-seven	mc
percent	percent	nnu
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
injecting	inject	vvg
heroin	heroin	nn1
in	in	ii
their	their	appge
lifetime	lifetime	nnt1
,	,	y
and	and	cc
78%	78%	nnu
reported	report	vvd_vvn
injecting	inject	vvg
heroin	heroin	nn1
in	in	ii
the	the	at
past	past	jj
6	6	mc
months	month	nnt2
.	.	y
Seventy-three	seventy-three	mc
percent	percent	nnu
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
in	in	ii
the	the	at
past	past	jj
6	6	mc
months	month	nnt2
.	.	y
Seventy-three	seventy-three	mc
percent	percent	nnu
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
injecting	inject	vvg
cocaine	cocaine	nn1
in	in	ii
their	their	appge
lifetime	lifetime	nnt1
,	,	y
while	while	cs
49%	49%	nnu
reported	report	vvd_vvn
injecting	inject	vvg
cocaine	cocaine	nn1
in	in	ii
the	the	at
past	past	jj
6	6	mc
months	month	nnt2
.	.	y
Approximately	approximately	rr
one-quarter	one-quarter	mf
(	(	y
n	xx_n	zz1
=	=	fo
90	90	mc
;	;	y
26%	26%	nnu
)	)	y
of	of	io
participants	participant	nn2
reported	report	vvd_vvn
graduating	graduate	vvg
from	from	ii
high	high	jj
school	school	nn1
,	,	y
with	with	iw
most	most	dat_rgt
(	(	y
40%	40%	nnu
)	)	y
participants	participant	nn2
reporting	reporting	nn1_vvg
having	have	vhg
some	some	dd
high	high	jj
school	school	nn1
education	education	nn1
.	.	y
Table	table	nn1_vv0%
1	1	mc1
summarizes	summarize	vvz
the	the	at
distributions	distribution	nn2
of	of	io
incarceration	incarceration	nn1
and	and	cc
demographic	demographic	jj
variables	variable	nn2
and	and	cc
their	their	appge
associations	association	nn2
with	with	iw
HCV	hcv	np1
prevalence	prevalence	nn1
.	.	y
The	the	at
unadjusted	unadjusted	jj
results	result	nn2
indicate	indicate	vv0
that	that	cst
when	when	cs
compared	compare	vvn
with	with	iw
drug	drug	nn1
users	user	nn2
having	have	vhg
no	no	at
high	high	jj
school	school	nn1
education	education	nn1
,	,	y
graduating	graduate	vvg
from	from	ii
high	high	jj
school	school	nn1
odds	odds	nn2
ratio	ratio	nn1
(	(	y
OR	or	cc
)	)	y
=	=	fo
0.3	0.3	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
0.1	0.1	mc
,	,	y
0.9	0.9	mc
and	and	cc
having	have	vhg
some	some	dd
college	college	nn1
experience	experience	nn1
(	(	y
OR	or	cc
=	=	fo
0.2	0.2	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
0.1-0.6		mcmc
)	)	y
produced	produce	vvd
a	a	at1
protective	protective	jj
effect	effect	nn1
against	against	ii
HCV	hcv	np1
infection	infection	nn1
.	.	y
Without	without	iw
adjustment	adjustment	nn1
,	,	y
the	the	at
prevalence	prevalence	nn1
of	of	io
HCV	hcv	np1
was	be	vbdz
significantly	significantly	rr
greater	great	jjr
among	among	ii
injection	injection	nn1
drug	drug	nn1
users	user	nn2
with	with	iw
a	a	at1
history	history	nn1
of	of	io
correctional	correctional	jj
facility	facility	nn1
incarceration	incarceration	nn1
(	(	y
83%	83%	nnu
)	)	y
(	(	y
OR	or	cc
=	=	fo
2.9	2.9	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
1.5-5.9		mcmc
)	)	y
,	,	y
when	when	cs_rrq
compared	compare	vvn
to	to	ii
drug	drug	nn1
users	user	nn2
with	with	iw
no	no	at
lifetime	lifetime	nnt1
incarceration	incarceration	nn1
(	(	y
61%	61%	nnu
)	)	y
.	.	y
Also	also	rr
without	without	iw
adjustment	adjustment	nn1
,	,	y
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
was	be	vbdz
highly	highly	rr
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
were	be	vbdr
twice	twice	rr
as	as	rg
likely	likely	jj
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
HCV	hcv	np1
(	(	y
OR	or	cc
=	=	fo
2.2	2.2	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
1.2	1.2	mc
,	,	y
4.3	4.3	mc
)	)	y
,	,	y
compared	compare	vvn
to	to	ii
participants	participant	nn2
reporting	report	vvg
less	less	dar_rrr
than	than	csn
1	1	mc1
year	year	nnt1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
.	.	y
The	the	at
odds	odds	nn2
of	of	io
HCV	hcv	np1
were	be	vbdr
greater	great	jjr
for	for	if
participants	participant	nn2
reporting	report	vvg
greater	great	jjr
than	than	csn
5	5	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
(	(	y
OR	or	cc
=	=	fo
7.6	7.6	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
4.1	4.1	mc
,	,	y
14.3	14.3	mc
)	)	y
.	.	y
Adjusting	adjust	vvg
for	for	if
gender	gender	nn1
,	,	y
age	age	nn1_vv0@
,	,	y
education	education	nn1
,	,	y
lifetime	lifetime	nnt1
incarceration	incarceration	nn1
status	status	nn1
and	and	cc
injection	injection	nn1
drug	drug	nn1
duration	duration	nn1
,	,	y
whites	white	nn2
were	be	vbdr
twice	twice	rr
as	as	rg
likely	likely	jj
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
HCV	hcv	np1
when	when	cs_rrq
compared	compare	vvn
to	to	ii
African	african	jj
Americans	american	nn2
(	(	y
adjusted	adjusted	jj@_vvn
odds	odds	nn2
ratio	ratio	nn1
AOR	aor	nn1_np1
=	=	fo
2.0	2.0	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
1.0-3.9		mcmc
)	)	y
.	.	y
The	the	at
significance	significance	nn1
of	of	io
the	the	at
association	association	nn1
between	between	ii
a	a	at1
correctional	correctional	jj
facility	facility	nn1
stay	stay	nn1@_vv0
and	and	cc
HCV	hcv	np1
infection	infection	nn1
was	be	vbdz
maintained	maintain	vvn
with	with	iw
adjustment	adjustment	nn1
(	(	y
AOR	aor	np1_nn1
=	=	fo
2.6	2.6	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
1.2	1.2	mc
,	,	y
6.1	6.1	mc
)	)	y
.	.	y
Additionally	additionally	rr
,	,	y
when	when	cs_rrq
compared	compare	vvn
against	against	ii
drug	drug	nn1
users	user	nn2
having	have	vhg
no	no	at
high	high	jj
school	school	nn1
education	education	nn1
,	,	y
having	have	vhg
some	some	dd
college	college	nn1
experience	experience	nn1
(	(	y
AOR	aor	np1_nn1
=	=	fo
0.3	0.3	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
0.1-1.0	0.1-1.0	mcmc
)	)	y
produced	produce	vvd
an	a	at1
independent	independent	jj
protective	protective	jj
effect	effect	nn1
against	against	ii
HCV	hcv	np1
infection	infection	nn1
.	.	y
ANALYSIS	analysis	nn1
STRATIFIED	stratify	vvn
BY	by	ii
RACE/ETHNICITY	race/ethnicity	nn1
Only	only	jj
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
other	other	jj
covariates	covariate	nn2
in	in	ii
the	the	at
multiple	multiple	jj_nn1
logistic	logistic	jj
regression	regression	nn1
model	model	nn1
.	.	y
Compared	compare	vvn
to	to	ii
African	african	jj
American	american	jj
participants	participant	nn2
who	who	pnqs
reported	report	vvd
less	less	dar_rrr
than	than	csn
1	1	mc1
year	year	nnt1
of	of	io
drug	drug	nn1
use	use	nn1_vv0
,	,	y
participants	participant	nn2
who	who	pnqs
reported	report	vvd
greater	great	jjr
than	than	csn
5	5	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
were	be	vbdr
about	about	rg
13	13	mc
times	time	nnt2
more	more	rrr_rgr
likely	likely	jj
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
HCV	hcv	np1
,	,	y
(	(	y
AOR	aor	np1_nn1
=	=	fo
13.3	13.3	mc
;	;	y
95%	95%	nnu
CI	ci	fo
=	=	fo
4.5	4.5	mc
,	,	y
39.5	39.5	mc
)	)	y
,	,	y
adjusting	adjust	vvg
for	for	if
gender	gender	nn1
,	,	y
age	age	nn1_vv0@
,	,	y
education	education	nn1
,	,	y
and	and	cc
lifetime	lifetime	nnt1
incarceration	incarceration	nn1
.	.	y
Though	though	cs
not	not	xx
identical	identical	jj
,	,	y
the	the	at
pattern	pattern	nn1
of	of	io
results	result	nn2
among	among	ii
white	white	jj
participants	participant	nn2
was	be	vbdz
similar	similar	jj
to	to	ii
that	that	dd1
of	of	io
the	the	at
entire	entire	jj
sample	sample	nn1
(	(	y
Table	table	nn1
2	2	mc
)	)	y
.	.	y
Namely	namely	rex
,	,	y
when	when	cs_rrq
compared	compare	vvn
against	against	ii
whites	white	nn2
having	have	vhg
no	no	at
high	high	jj
school	school	nn1
education	education	nn1
,	,	y
whites	white	nn2
having	have	vhg
some	some	dd
college	college	nn1
exhibited	exhibit	vvn
significantly	significantly	rr
lower	low	jjr_rrr@
HCV	hcv	np1
infection	infection	nn1
prevalence	prevalence	nn1
.	.	y
Correctional	correctional	jj
facility	facility	nn1
stay	stay	nn1@_vv0
and	and	cc
longer	long	jjr
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
in	in	ii
both	both	db2
the	the	at
unadjusted	unadjusted	jj
and	and	cc
adjusted	adjusted	jj@_vvn
models	model	nn2
were	be	vbdr
associated	associate	vvn
with	with	iw
higher	high	jjr
HCV	hcv	np1
prevalence	prevalence	nn1
.	.	y
In	in	ii
adjusted	adjusted	jj@
models	model	nn2
,	,	y
injectors	injector	nn2
with	with	iw
a	a	at1
history	history	nn1
of	of	io
correction	correction	nn1
facility	facility	nn1
stay	stay	nn1@
were	be	vbdr
nearly	nearly	rr
15	15	mc
times	time	nnt2
more	more	rrr_rgr
likely	likely	jj
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
HCV	hcv	np1
when	when	cs_rrq
compared	compare	vvn
to	to	ii
injectors	injector	nn2
with	with	iw
no	no	at
history	history	nn1
of	of	io
incarceration	incarceration	nn1
(	(	y
AOR	aor	np1_nn1
=	=	fo
14.7	14.7	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
2.9	2.9	mc
,	,	y
79.5	79.5	mc
)	)	y
.	.	y
Drug	drug	nn1
users	user	nn2
with	with	iw
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
HCV	hcv	np1
when	when	cs_rrq
compared	compare	vvn
to	to	ii
drug	drug	nn1
users	user	nn2
with	with	iw
less-than	less	csn
one	one	mc1
year	year	nnt1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
(	(	y
AOR	aor	np1_nn1
=	=	fo
4.6	4.6	mc
,	,	y
95%	95%	nnu
CI	ci	fo
=	=	fo
1.8	1.8	mc
,	,	y
12.0	12.0	mc
)	)	y
.	.	y
DISCUSSION	discussion	nn1
Our	our	appge
study	study	nn1
findings	finding	nn2
are	be	vbr
consistent	consistent	jj
with	with	iw
a	a	at1
large	large	jj
base	base	nn1
of	of	io
research	research	nn1
documenting	document	vvg
high	high	jj
rates	rate	nn2
of	of	io
HCV	hcv	np1
among	among	ii
incarcerated	incarcerated	jj@
populations	population	nn2
(	(	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
.	.	y
The	the	at
overall	overall	jj_nn1
rates	rate	nn2
of	of	io
HCV	hcv	np1
prevalence	prevalence	nn1
associated	associate	vvn
with	with	iw
various	various	jj
levels	level	nn2
of	of	io
incarceration	incarceration	nn1
found	find	vvn_vvd
in	in	ii_rp@
our	our	appge
study	study	nn1
are	be	vbr
higher	high	jjr
than	than	csn
rates	rate	nn2
of	of	io
HCV	hcv	np1
found	find	vvd
in	in	ii_rp@
extant	extant	jj
studies	study	nn2
of	of	io
general	general	jj_nn1
populations	population	nn2
of	of	io
incarcerated	incarcerated	jj@
adults	adult	nn2
.	.	y
In	in	ii
these	these	dd2
studies	study	nn2
,	,	y
rates	rate	nn2
of	of	io
HCV	hcv	np1
prevalence	prevalence	nn1
ranged	range	vvn_vvd
from	from	ii
16%	16%	nnu
to	to	ii
41%	41%	nnu
(	(	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
;	;	y
Reindollar		np1
,	,	y
1999	1999	mc
;	;	y
Solomon	solomon	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
;	;	y
Vlahov	vlahov	np1
et	et	ra21
al.	al	ra22
,	,	y
1993	1993	mc
)	)	y
.	.	y
Consistent	consistent	jj
with	with	iw
previous	previous	jj
research	research	nn1
with	with	iw
drug	drug	nn1
using	use	vvg
and	and	cc
incarcerated	incarcerate	vvd_jj@
populations	population	nn2
,	,	y
whites	white	nn2_vvz@
in	in	ii
our	our	appge
study	study	nn1
were	be	vbdr
significantly	significantly	rr
more	more	rgr
likely	likely	jj
than	than	csn
African	african	jj
Americans	american	nn2
to	to	to
test	test	vvi
positive	positive	jj
for	for	if
hepatitis	hepatitis	nn1
C	c	zz1_np1
(	(	y
Baillargeon	baillargeon	np1
et	et	ra21
al.	al	ra22
,	,	y
2003	2003	mc
;	;	y
Ruiz	ruiz	np1
et	et	ra21
al.	al	ra22
,	,	y
1999	1999	mc
;	;	y
Solomon	solomon	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
)	)	y
.	.	y
Past	past	jj_ii_nn1
studies	study	nn2
either	either	rr_dd1
did	do	vdd
not	not	xx
control	control	vvi
for	for	if
injection	injection	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
et	et	ra21
al.	al	ra22
,	,	y
1999	1999	mc
)	)	y
,	,	y
or	or	cc
included	include	vvd_vvn
both	both	rr
non-injectors		nn2
and	and	cc
injectors	injector	nn2
(	(	y
Ruiz	ruiz	np1
et	et	ra21
al.	al	ra22
,	,	y
1999	1999	mc
;	;	y
Solomon	solomon	np1
et	et	ra21
al.	al	ra22
,	,	y
2004	2004	mc
)	)	y
.	.	y
In	in	ii
our	our	appge
sample	sample	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
users	user	nn2
,	,	y
when	when	cs
controlling	control	vvg
for	for	if
potentially	potentially	rr
influential	influential	jj
covariates	covariate	nn2
such	such	ii21
as	as	ii22
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
,	,	y
the	the	at
odds	odds	nn2
of	of	io
HCV	hcv	np1
infection	infection	nn1
for	for	if
whites	white	nn2
compared	compare	vvn
to	to	ii
African	african	jj
Americans	american	nn2
increased	increase	vvn_vvd
.	.	y
Furthermore	furthermore	rr
,	,	y
the	the	at
stratified	stratified	jj
analyses	analysis	nn2
indicate	indicate	vv0
that	that	cst
the	the	at
duration	duration	nn1
of	of	io
injection	injection	nn1
and	and	cc
type	type	nn1
of	of	io
incarceration	incarceration	nn1
differs	differ	vvz
by	by	ii
race	race	nn1
.	.	y
These	these	dd2
differences	difference	nn2
may	may	vm
explain	explain	vvi
why	why	rrq
HCV	hcv	np1
is	be	vbz
higher	high	jjr
among	among	ii
whites	white	nn2
compared	compare	vvn
to	to	ii
African	african	jj
Americans	american	nn2
in	in	ii
incarcerated	incarcerated	jj@
populations	population	nn2
,	,	y
compared	compare	vvn
to	to	ii
the	the	at
opposite	opposite	jj
effect	effect	nn1
in	in	ii_rr21
general	general	jj_rr22
populations	population	nn2
.	.	y
That	that	rex21
is	is	rex22
,	,	y
although	although	cs
a	a	at1
higher	high	jjr
percentage	percentage	nn1
of	of	io
African	african	jj
Americans	american	nn2
reported	report	vvd_vvn
correctional	correctional	jj
facility	facility	nn1
stays	stay	nn2_vvz
compared	compare	vvn
to	to	ii
whites	white	nn2
,	,	y
whites	white	nn2
who	who	pnqs
reported	report	vvd
correctional	correctional	jj
facility	facility	nn1
stays	stay	nn2
had	have	vhd
a	a	at1
higher	high	jjr
prevalence	prevalence	nn1
of	of	io
HCV	hcv	np1
infection	infection	nn1
compared	compare	vvn
to	to	ii
African	african	jj
Americans	american	nn2
,	,	y
96.0%	96.0%	fo
versus	versus	ii
72.3%	72.3%	fo
respectively	respectively	rr
.	.	y
Whereas	whereas	cs
HCV	hcv	np1
infection	infection	nn1
was	be	vbdz
similar	similar	jj
among	among	ii
whites	white	nn2
and	and	cc
African	african	jj
Americans	american	nn2
who	who	pnqs
reported	report	vvd
greater	great	jjr
than	than	csn
five	five	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
(	(	y
84.2	84.2	mc
versus	versus	ii
83.5	83.5	mc
,	,	y
respectively	respectively	rr
)	)	y
,	,	y
HCV	hcv	np1
infection	infection	nn1
was	be	vbdz
greater	great	jjr
in	in	ii
whites	white	nn2
compared	compare	vvn
to	to	ii
African	african	jj
American	american	nn1@
who	who	pnqs
reported	report	vvd
less	less	dar_rrr
than	than	csn
1	1	mc1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
respectively	respectively	rr
)	)	y
,	,	y
and	and	cc
who	who	pnqs
reported	report	vvd
one	one	mc1
to	to	ii
five	five	mc
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
(	(	y
64.3	64.3	mc
versus	versus	ii
47.4	47.4	mc
,	,	y
respectively	respectively	rr
)	)	y
.	.	y
Further	far	jjr
studies	study	nn2
need	need	vv0
to	to	to
delineate	delineate	vvi
why	why	rrq
HCV	hcv	np1
rates	rate	nn2
are	be	vbr
higher	high	jjr
among	among	ii
incarcerated	incarcerated	jj@
whites	white	nn2
who	who	pnqs
report	report	vv0@
fewer	fewer	dar
years	year	nnt2
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
compared	compare	vvn
to	to	ii
incarcerated	incarcerated	jj@
African	african	jj
Americans	american	nn2
.	.	y
That	that	rex21
is	is	rex22
,	,	y
future	future	jj_nn1
studies	study	nn2
may	may	vm
want	want	vvi
to	to	to
control	control	vvi
for	for	if
not	not	xx
only	only	rr
the	the	at
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
but	but	ccb
also	also	rr
the	the	at
frequency	frequency	nn1
of	of	io
use	use	nn1
and	and	cc
high-risk	high-risk	jj
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
practices	practice	nn2
(	(	y
e.g.	eg	rex
,	,	y
sharing	share	vvg
needles	needle	nn2
,	,	y
backloading	backloading	vvg
,	,	y
etc	etc	ra
.	.	y
)	)	y
.	.	y
Further	far	rrr_jjr
,	,	y
exploration	exploration	nn1
of	of	io
risk	risk	nn1
factors	factor	nn2
for	for	if
HCV	hcv	np1
other	other	ii21
than	than	ii22
injection	injection	nn1
drug	drug	nn1
use	use	nn1_vv0
,	,	y
such	such	ii21
as	as	ii22
sexual	sexual	jj
risk	risk	nn1
factors	factor	nn2
,	,	y
may	may	vm
need	need	vvi
to	to	to
be	be	vbi
delineated	delineate	vvn
by	by	ii
race	race	nn1
.	.	y
Given	give	vvn
research	research	nn1
conducted	conduct	vvn_vvd
in	in	ii
the	the	at
general	general	jj_nn1
population	population	nn1
that	that	cst_dd1
has	have	vhz
shown	show	vvn
African	african	jj
Americans	american	nn2
to	to	to
be	be	vbi
at	at	ii
greater	great	jjr
risk	risk	nn1
to	to	to
contract	contract	vvi
HCV	hcv	np1
than	than	csn
whites	white	nn2
,	,	y
the	the	at
higher	high	jjr
prevalence	prevalence	nn1
of	of	io
HCV	hcv	np1
among	among	ii
incarcerated	incarcerated	jj@
whites	white	nn2
than	than	csn
among	among	ii
incarcerated	incarcerated	jj@
African	african	jj
Americans	american	nn2
is	be	vbz
noteworthy	noteworthy	jj
.	.	y
The	the	at
differing	differing	jj
base	base	nn1
rates	rate	nn2
of	of	io
incarceration	incarceration	nn1
among	among	ii
African	african	jj
Americans	american	nn2
and	and	cc
whites	white	nn2_vvz@
in	in	ii
the	the	at
United	united	np1
States	state	np1
could	could	vm
be	be	vbi
a	a	at1
further	far	jjr@
explanation	explanation	nn1
for	for	if
this	this	dd1
finding	finding	nn1
.	.	y
It	it	pph1
is	be	vbz
well	well	rr
documented	document	vvn_vvd
that	that	cst
the	the	at
U.S.	us	np1
incarcerates	incarcerate	vvz
a	a	at1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
8	8	mc
times	time	nnt2
that	that	dd1
of	of	io
other	other	jj
industrialized	industrialized	jj
nations	nation	nn2
(	(	y
Harrison	harrison	np1
,	,	y
2003	2003	mc
;	;	y
Thomas	thomas	np1
&;		null
Sampson	sampson	np1
,	,	y
2005	2005	mc
)	)	y
.	.	y
The	the	at
rate	rate	nn1
of	of	io
incarceration	incarceration	nn1
in	in	ii
the	the	at
United	united	np1
States	state	np1
has	have	vhz
increased	increase	vvn
by	by	ii
more-than	more-than	csn
200%	200%	nnu
during	during	ii
the	the	at
past	past	jj
20	20	mc
years	year	nnt2
,	,	y
attributable	attributable	jj
mainly	mainly	rr
to	to	ii
a	a	at1
growth	growth	nn1
in	in	ii
the	the	at
prosecution	prosecution	nn1
of	of	io
drug-related	drug-related	jj_nn1
offenses	offense	nn2
(	(	y
Macalino	macalino	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
.	.	y
Further	far	rrr_jjr
,	,	y
while	while	cs
African	african	jj
Americans	american	nn2
comprise	comprise	vv0
12.3%	12.3%	fo
of	of	io
the	the	at
population	population	nn1
,	,	y
they	they	pphs2
comprise	comprise	vv0
43.7%	43.7%	fo
of	of	io
incarcerated	incarcerated	jj@
individuals	individual	nn2
(	(	y
Bonczar		np1
&;		null
Beck	beck	np1
,	,	y
1997	1997	mc
;	;	y
Braithwaite	braithwaite	np1
&;		null
Arriola	arriola	np1
,	,	y
2003	2003	mc
)	)	y
.	.	y
Equally	equally	rr
alarming	alarming	jj_vvg@
is	be	vbz
the	the	at
one-in-eight	one-in-eight	mc
rate	rate	nn1
of	of	io
incarceration	incarceration	nn1
among	among	ii
African	african	jj
American	american	jj
males	male	nn2
aged	age	vvn_ii@_vvd@
25-29	25-29	mcmc
years	year	nnt2
(	(	y
Bonczar		np1
&;		null
Beck	beck	np1
,	,	y
1997	1997	mc
)	)	y
.	.	y
To	to	ii
the	the	at
extent	extent	nn1
that	that	cst_dd1
incarceration	incarceration	nn1
is	be	vbz
less	less	rgr
likely	likely	jj
for	for	if
whites	white	nn2
than	than	csn
African	african	jj
Americans	american	nn2
for	for	if
drug-related	drug-related	jj_nn1
offenses	offense	nn2_vvz
,	,	y
whites	white	nn2
who	who	pnqs
serve	serve	vv0
sentences	sentence	nn2
may	may	vm
have	have	vhi
higher	high	jjr
levels	level	nn2
of	of	io
drug	drug	nn1
use	use	nn1_vv0
,	,	y
infectious	infectious	jj
disease	disease	nn1
,	,	y
and	and	cc
pathology	pathology	nn1
than	than	csn
incarcerated	incarcerated	jj@_vvd_vvn@
African	african	jj
Americans	american	nn2
.	.	y
The	the	at
stratified	stratified	jj
findings	finding	nn2
also	also	rr
have	have	vh0
relevance	relevance	nn1
to	to	ii
the	the	at
prevention	prevention	nn1
of	of	io
HCV	hcv	np1
among	among	ii
African	african	jj
American	american	jj_nn1@
and	and	cc
white	white	jj
populations	population	nn2
of	of	io
drug	drug	nn1
users	user	nn2
.	.	y
Consistent	consistent	jj
with	with	iw
extant	extant	jj
studies	study	nn2
,	,	y
longer	long	jjr
duration	duration	nn1
of	of	io
injection	injection	nn1
drug	drug	nn1
use	use	nn1
was	be	vbdz
associated	associate	vvn
with	with	iw
HCV	hcv	np1
prevalence	prevalence	nn1
among	among	ii
African	african	jj
Americans	american	nn2
and	and	cc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
findings	finding	nn2
suggest	suggest	vv0
the	the	at
need	need	nn1
for	for	if
behavioral	behavioral	jj
pharmacological	pharmacological	jj
interventions	intervention	nn2
at	at	ii
each	each	dd1
level	level	nn1
of	of	io
incarceration	incarceration	nn1
(	(	y
e.g.	eg	rex
,	,	y
from	from	ii
detentions	detention	nn2
and	and	cc
jails	jail	nn2
to	to	ii
prisons	prison	nn2
)	)	y
to	to	to
reduce	reduce	vvi
the	the	at
use	use	nn1
of	of	io
illegal	illegal	jj
substances	substance	nn2
especially	especially	rr
,	,	y
IDU	idu	np1_nn1
,	,	y
which	which	ddq
often	often	rr
involves	involve	vvz
sharing	share	vvg_jj@
injection	injection	nn1
equipment	equipment	nn1
among	among	ii
incarcerated	incarcerated	jj@
populations	population	nn2
.	.	y
Consideration	consideration	nn1
of	of	io
several	several	da2
limitations	limitation	nn2
of	of	io
this	this	dd1
study	study	nn1
is	be	vbz
now	now	rt
discussed	discuss	vvn
.	.	y
Notably	notably	rr
,	,	y
despite	despite	ii
being	be	vbg
of	of	io
comparable	comparable	jj
size	size	nn1
to	to	ii
several	several	da2
studies	study	nn2
of	of	io
adult	adult	nn1_jj@
injection	injection	nn1
drug	drug	nn1
users	user	nn2
,	,	y
this	this	dd1
sample	sample	nn1
was	be	vbdz
relatively	relatively	rr
small	small	jj
,	,	y
particularly	particularly	rr
with	with	ii31
respect	respect	ii32
to	to	ii33
the	the	at
stratified	stratified	jj
analysis	analysis	nn1
for	for	if
some	some	dd
variables	variable	nn2
.	.	y
Additionally	additionally	rr
,	,	y
sufficient	sufficient	jj
representation	representation	nn1
of	of	io
ethnic/racial	ethnic/racial	jj
groups	group	nn2
other	other	ii21
than	than	ii22
African	african	jj
American	american	jj_nn1@
and	and	cc
white	white	jj_nn1@
in	in	ii
the	the	at
study	study	nn1
sample	sample	nn1
did	do	vdd
not	not	xx
allow	allow	vvi
for	for	if
generalization	generalization	nn1
to	to	ii
other	other	jj
ethnicity	ethnicity	nn1
groups	group	nn2
.	.	y
Further	far	rrr_jjr
,	,	y
the	the	at
cross-sectional	cross-sectional	jj
data	data	nn
utilized	utilize	vvn_vvd
in	in	ii
the	the	at
present	present	jj_nn1
study	study	nn1
limits	limit	vvz
the	the	at
capacity	capacity	nn1
to	to	to
infer	infer	vvi
causal	causal	jj
relationships	relationship	nn2
.	.	y
Future	future	jj_nn1
studies	study	nn2
will	will	vm
need	need	vvi
to	to	to
evaluate	evaluate	vvi
the	the	at
present	present	jj_nn1
study	study	nn1
findings	finding	nn2
in	in	ii31
light	light	ii32
of	of	ii33
incidence	incidence	nn1
data	data	nn
that	that	cst
provide	provide	vv0
a	a	at1
more	more	rgr
precise	precise	jj
measure	measure	nn1
of	of	io
the	the	at
nature	nature	nn1
of	of	io
an	a	at1
epidemic	epidemic	nn1
.	.	y
Despite	despite	ii
these	these	dd2
important	important	jj
limitations	limitation	nn2
,	,	y
the	the	at
present	present	jj_nn1
study	study	nn1
design	design	nn1
and	and	cc
sampling	sample	vvg_nn1
method	method	nn1
provide	provide	vv0
contributions	contribution	nn2
to	to	ii
the	the	at
HCV	hcv	np1
literature	literature	nn1
,	,	y
particularly	particularly	rr
with	with	ii31
respect	respect	ii32
to	to	ii33
insights	insight	nn2
into	into	ii
possible	possible	jj
foci	focus	nn2
of	of	io
prevention	prevention	nn1
programs	program	nn2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
throughout	throughout	ii
the	the	at
United	united	np1
States	state	np1
do	do	vd0
not	not	xx
incorporate	incorporate	vvi
systematic	systematic	jj
HCV	hcv	np1
screening	screening	nn1_vvg
or	or	cc
prevention	prevention	nn1
programs	program	nn2
for	for	if
inmates	inmate	nn2
(	(	y
Braithwaite	braithwaite	np1
&;		null
Arriola	arriola	np1
,	,	y
2003	2003	mc
;	;	y
Hammett	hammett	np1
et	et	ra21
al.	al	ra22
,	,	y
2002	2002	mc
)	)	y
.	.	y
A	a	at1_zz1
growing	growing	jj
base	base	nn1
of	of	io
empirical	empirical	jj
research	research	nn1
strongly	strongly	rr
suggests	suggest	vvz
that	that	cst
the	the	at
absence	absence	nn1
of	of	io
such	such	da
programming	programming	nn1
represents	represent	vvz
a	a	at1
lost	lost	jj@
opportunity	opportunity	nn1
to	to	to
improve	improve	vvi
public	public	jj_nn1
health	health	nn1
within	within	ii
society	society	nn1
as	as	ii
a	a	at1
whole	whole	nn1
as	as	ii31_rg
well	well	ii32_rr
as	as	ii33_csa
among	among	ii
inmates	inmate	nn2
and	and	cc
those	those	dd2
released	release	vvn
from	from	ii
incarceration	incarceration	nn1
.	.	y
When	when	cs
an	a	at1
estimated	estimated	jj@
30%	30%	nnu
to	to	ii
90%	90%	nnu
of	of	io
drug	drug	nn1
users	user	nn2
with	with	iw
a	a	at1
history	history	nn1
of	of	io
incarceration	incarceration	nn1
are	be	vbr
seropositive	seropositive	jj
for	for	if
HCV	hcv	np1
,	,	y
the	the	at
utility	utility	nn1
of	of	io
providing	provide	vvg
systematic	systematic	jj
screening	screening	nn1
and	and	cc
prevention	prevention	nn1
efforts	effort	nn2
within	within	ii
jails	jail	nn2
and	and	cc
correctional	correctional	jj
facilities	facility	nn2
is	be	vbz
clear	clear	jj
.	.	y
The	the	at
significance	significance	nn1
of	of	io
such	such	da
programming	programming	nn1
for	for	if
the	the	at
prevention	prevention	nn1
of	of	io
subsequent	subsequent	jj
HCV	hcv	np1
transmission	transmission	nn1
in	in	ii
the	the	at
general	general	jj_nn1
population	population	nn1
is	be	vbz
necessary	necessary	jj
when	when	cs
considered	consider	vvn
in	in	ii31
light	light	ii32
of	of	ii33
the	the	at
estimated	estimated	jj@
7	7	mc
million	million	m1
inmates	inmate	nn2
released	release	vvn
from	from	ii
jails	jail	nn2
or	or	cc
correctional	correctional	jj
institutions	institution	nn2
annually	annually	rr
.	.	y
ACKNOWLEDGEMENT	acknowledgement	nn1
The	the	at
authors	author	nn2
would	would	vm
like	like	vvi
to	to	to
thank	thank	vvi
the	the	at
study	study	nn1
staff	staff	nn
and	and	cc
participants	participant	nn2
and	and	cc
Dr.	dr	nnb
David	david	np1
Celentano	celentano	np1_nn1
for	for	if
project	project	nn1
consultation	consultation	nn1
.	.	y
This	this	dd1
research	research	nn1
was	be	vbdz
made	make	vvn
possible	possible	jj
with	with	iw
support	support	nn1
from	from	ii
NIDA	nida	np1_nn1
(	(	y
R01	r01	fo
DA014498		fo
)	)	y
and	and	cc
NIDA	nida	np1_nn1
Training	training	nn1
Program	program	nn1
(	(	y
T32DA007292		fo
)	)	y
for	for	if
S.	s	zz
Geoffrey	geoffrey	np1
Severtson		np1
.	.	y
Table	table	nn1_vv0%
1	1	mc1
:	:	y
Associations	association	nn2
of	of	io
HCV	hcv	np1
Infection	infection	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Alter	alter	vv0
,	,	y
M.J.	mj	np1
1997	1997	mc
Epidemiology	epidemiology	nn1
of	of	io
hepatitis	hepatitis	nn1
C.	c	np1
Hepatology	hepatology	np1
,	,	y
26(S3)		fo
,	,	y
62S-65S		mc2
.	.	y
Alter	alter	vv0
,	,	y
M.J.	mj	np1
,	,	y
&;		null
Mast	mast	nn1
,	,	y
E.E	ee	np1
.	.	y
1994	1994	mc
The	the	at
epidemiology	epidemiology	nn1
of	of	io
viral	viral	jj
hepatitis	hepatitis	nn1
in	in	ii
the	the	at
United	united	np1
States	state	np1
.	.	y
Gastroenterology	gastroenterology	nn1_np1@
Clinics	clinic	nn2
of	of	io
North	north	nd1
America	america	np1
,	,	y
23(3)	23(3)	fo
,	,	y
437-455		mcmc
.	.	y
Baillargeon	baillargeon	nn1_np1@
,	,	y
J.	xx_j	np1
,	,	y
Wu	wu	np1_nn1
,	,	y
H.	h	np1
,	,	y
Kelley	kelley	np1_nn1
,	,	y
M.J.	mj	np1
,	,	y
Grady	grady	np1_nn1
,	,	y
J.	xx_j	np1
,	,	y
Linthicum	linthicum	np1_nn1
,	,	y
L.	l	zz
,	,	y
&;		null
Dunn	dunn	np1
,	,	y
K.	k	np1
2003	2003	mc
Hepatitis	hepatitis	np1
C	c	np1_zz1
seroprevalence	seroprevalence	nn1
among	among	ii
newly	newly	rr
incarcerated	incarcerate	vvd_jj@
inmates	inmate	nn2
in	in	ii
the	the	at
Texas	texas	np1
correctional	correctional	jj
system	system	nn1
.	.	y
Public	public	jj_nn1
Health	health	nn1
,	,	y
117(1)		fo
,	,	y
43-48	43-48	mcmc
.	.	y
Bonczar	bonczar	vv0_nn1_np1@
,	,	y
T.P.	tp	np1
,	,	y
&;		null
Beck	beck	np1
,	,	y
A.J.	aj	np1
1997	1997	mc
Lifetime	lifetime	nnt1
likelihood	likelihood	nn1
of	of	io
going	go	vvgk
to	to	to
state	state	vvi
or	or	cc
federal	federal	jj
prison	prison	nn1
.	.	y
Washington	washington	np1
,	,	y
DC	dc	np1
:	:	y
Bureau	bureau	nn1
of	of	io
Justice	justice	nn1
Statistics	statistics	nn
.	.	y
Braithwaite	braithwaite	np1
,	,	y
R.L.	rl	np1
,	,	y
&;		null
Arriola	arriola	np1
,	,	y
K.R.	kr	np1
2003	2003	mc
Male	male	jj
prisoners	prisoner	nn2
and	and	cc
HIV	hiv	np1
prevention	prevention	nn1
:	:	y
A	a	zz1_at1@
call	call	vv0_nn1
for	for	if
action	action	nn1
ignored	ignore	vvd_vvn
.	.	y
American	american	jj
Journal	journal	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
93(5)	93(5)	fo
,	,	y
759-763		mcmc
.	.	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
2008	2008	mc
Viral	viral	jj
hepatitis	hepatitis	nn1
C	c	np1_zz1
:	:	y
Fact	fact	nn1
sheet	sheet	nn1
,	,	y
http		nnu
:	:	y
**50;22798;TOOLONG		fu
.	.	y
Fleckenstein	fleckenstein	nn1_np1@
,	,	y
J.	xx_j	np1
2004	2004	mc
Chronic	chronic	jj
hepatitis	hepatitis	nn1
C	c	zz1_np1
in	in	ii
African	african	jj
Americans	american	nn2
and	and	cc
other	other	jj
minority	minority	nn1
groups	group	nn2
.	.	y
Current	current	jj
Gastroenterolology	gastroenterolology	nn1
Reports	report	nn2_vvz
,	,	y
6(1)	6(1)	fo
,	,	y
66-70	66-70	mcmc
.	.	y
Galeazzi	galeazzi	nn2_np1@
,	,	y
B.	b	np1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
F.	f	np1_ra@
1995	1995	mc
Hepatitis	hepatitis	np1
C	c	np1_zz1
virus	virus	nn1
infection	infection	nn1
in	in	ii
Italian	italian	jj
intravenous	intravenous	jj
drug	drug	nn1
users	user	nn2
:	:	y
Epidemiological	epidemiological	np1_jj
and	and	cc
clinical	clinical	jj
aspects	aspect	nn2
.	.	y
Liver	liver	nn1
,	,	y
15(4)	15(4)	fo
,	,	y
209-212		mcmc
.	.	y
Garfein	garfein	nn1_np1@
,	,	y
R.S.	r.s	nn1
,	,	y
Vlahov	vlahov	np1
,	,	y
D.	d	np1
,	,	y
Galai	galai	np1_nn1
,	,	y
N.	xx_n	np1_nnu
,	,	y
Doherty	doherty	np1_nn1
,	,	y
M.C.	mc	nn1
,	,	y
&;		null
Nelson	nelson	np1
,	,	y
K.E.	ke	np1
1996	1996	mc
Viral	viral	jj
infections	infection	nn2
in	in	ii
short-term	short-term	jj
injection	injection	nn1
drug	drug	nn1
users	user	nn2
:	:	y
The	the	at
prevalence	prevalence	nn1
of	of	io
the	the	at
hepatitis	hepatitis	nn1
C	c	zz1_np1
,	,	y
hepatitis	hepatitis	nn1
B	b	zz1
,	,	y
human	human	jj_nn1
immunodeficiency	immunodeficiency	nn1
,	,	y
and	and	cc
human	human	jj
T-lymphotropic	t-lymphotropic	jj
viruses	virus	nn2
.	.	y
American	american	jj
Journal	journal	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
86(5)		fo
,	,	y
655-661		mcmc
.	.	y
Hagan	hagan	nn1_np1@
,	,	y
H.	h	np1
,	,	y
Des	des	np1_fw
Jarlais	jarlais	np1_nn1
,	,	y
D.C.	d.c	np1
,	,	y
Stern	stern	nn1_jj
,	,	y
R.	xx_r	np1
,	,	y
Lelutiu-Weinberger		np1
,	,	y
C.	c	np1_zz1@
,	,	y
Scheinmann		np1
,	,	y
R.	xx_r	np1
,	,	y
Strauss	strauss	np1
,	,	y
S.	s	zz
,	,	y
&;		null
Flom	flom	np1_vv0_nn1
,	,	y
P.L.	pl	np1_nn1
2007	2007	mc
HCV	hcv	np1
synthesis	synthesis	nn1
project	project	nn1
:	:	y
Preliminary	preliminary	jj
analyses	analysis	nn2
of	of	io
HCV	hcv	np1
prevalence	prevalence	nn1
in	in	ii31
relation	relation	ii32
to	to	ii33
age	age	nn1
and	and	cc
duration	duration	nn1
of	of	io
injection	injection	nn1
.	.	y
International	international	jj
Journal	journal	nn1
of	of	io
Drug	drug	nn1
Policy	policy	nn1
,	,	y
18(5)		fo
,	,	y
341-51		mcmc
.	.	y
Epub	epub	vv0_nn1
2007	2007	mc
May	may	npm1
2	2	mc
.	.	y
Hammett	hammett	vv0_nn1_np1@
,	,	y
T.M.	tm	np1
,	,	y
Harmon	harmon	np1_nn1
,	,	y
M.P.	m.p	nna
,	,	y
&;		null
Rhodes	rhodes	np1
,	,	y
W.	w	np1
2002	2002	mc
The	the	at
burden	burden	nn1
of	of	io
infectious	infectious	jj
disease	disease	nn1
among	among	ii
inmates	inmate	nn2
of	of	io
and	and	cc
releasees		nn2
from	from	ii
US	us	np1_ppio2@
correctional	correctional	jj
facilities	facility	nn2
,	,	y
1997	1997	mc
.	.	y
American	american	jj
Journal	journal	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
92(11)		fo
,	,	y
1789-1794	1789-1794	mcmc
.	.	y
Harrison	harrison	np1
,	,	y
P.M.	pm	ra_np1
,	,	y
K.J.	kj	np1
2003	2003	mc
Prison	prison	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
:	:	y
Bureau	bureau	nn1
of	of	io
Justice	justice	nn1
Statistics	statistics	nn
.	.	y
Macalino	macalino	np1
,	,	y
G.E.	g.e	np1
,	,	y
Vlahov	vlahov	np1
,	,	y
D.	d	np1
,	,	y
Dickinson	dickinson	np1
,	,	y
B.P.	bp	np1
,	,	y
Schwartzapfel		np1
,	,	y
B.	b	np1
,	,	y
&;		null
Rich	rich	jj_np1@
,	,	y
J.D.	jd	np1
2005	2005	mc
Community	community	nn1
incidence	incidence	nn1
of	of	io
hepatitis	hepatitis	nn1
B	b	zz1
and	and	cc
C	c	zz1_np1
among	among	ii
reincarcerated	reincarcerated	jj@
women	woman	nn2
.	.	y
Clinical	clinical	jj
Infectious	infectious	jj
Disease	disease	nn1
,	,	y
41(7)		fo
,	,	y
998-1002		mcmc
.	.	y
Macalino	macalino	np1
,	,	y
G.E.	g.e	np1
,	,	y
Vlahov	vlahov	np1
,	,	y
D.	d	np1
,	,	y
Sanford-Colby		np1
,	,	y
S.	s	zz
,	,	y
Patel	patel	np1
,	,	y
S.	s	zz
,	,	y
Sabin	sabin	np1
,	,	y
K.	k	np1
,	,	y
Salas	sala	np2_nn2@
,	,	y
C.	c	np1_zz1@
,	,	y
&;		null
Rich	rich	jj_np1@
,	,	y
J.D.	jd	np1
2004	2004	mc
Prevalence	prevalence	np1
and	and	cc
incidence	incidence	nn1
of	of	io
HIV	hiv	np1
,	,	y
hepatitis	hepatitis	nn1
B	b	zz1
virus	virus	nn1
,	,	y
and	and	cc
hepatitis	hepatitis	nn1
C	c	zz1_np1
virus	virus	nn1
infections	infection	nn2
among	among	ii
males	male	nn2
in	in	ii
Rhode	rhode	np1
Island	island	nnl1
prisons	prison	nn2
.	.	y
American	american	jj
Journal	journal	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
94(7)		fo
,	,	y
1218-1223		mcmc
.	.	y
Pyrsopoulos		nn2_np1@
,	,	y
N.	xx_n	np1_nnu
,	,	y
&;		null
Jeffers	jeffers	np1
,	,	y
L.	l	zz
2007	2007	mc
Hepatitis	hepatitis	np1
C	c	np1_zz1
in	in	ii
African	african	jj
Americans	american	nn2
.	.	y
Journal	journal	nn1
of	of	io
Clinical	clinical	jj
Gastroenterology	gastroenterology	nn1_np1
,	,	y
41(2)	41(2)	fo
,	,	y
185-193		mcmc
.	.	y
Rawls	rawls	np1
,	,	y
R.A.	r.a	nna
,	,	y
&;		null
Vega	vega	np1
,	,	y
K.J.	kj	np1
2005	2005	mc
Viral	viral	jj
hepatitis	hepatitis	nn1
in	in	ii
minority	minority	nn1
America	america	np1
.	.	y
Journal	journal	nn1
of	of	io
Clinical	clinical	jj
Gastroenterology	gastroenterology	nn1_np1
,	,	y
39(2)		fo
,	,	y
144-151		mcmc
.	.	y
Reindollar		np1@_jj
,	,	y
R.W.	rw	np1
1999	1999	mc
Hepatitis	hepatitis	np1_nn1
C	c	np1_zz1
and	and	cc
the	the	at
correctional	correctional	jj
population	population	nn1
.	.	y
The	the	at
American	american	jj
Journal	journal	nn1
of	of	io
Medicine	medicine	nn1
,	,	y
107(6B)		fo
,	,	y
100S-103S		mc2
.	.	y
Ruiz	ruiz	vv0_nn1_np1@
,	,	y
J.D.	jd	np1
,	,	y
Molitor	molitor	np1_nn1
,	,	y
F.	f	np1_ra@
,	,	y
Sun	sun	nn1
,	,	y
R.K.	rk	np1
,	,	y
Mikanda	mikanda	np1
,	,	y
J.	xx_j	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
G.W.	gw	np1
,	,	y
Jr.	jr	np1
,	,	y
&;		null
Ascher	ascher	np1_nn1
,	,	y
M.S.	ms	nn1_nnb
1999	1999	mc
Prevalence	prevalence	np1
and	and	cc
correlates	correlate	nn2@_vvz
of	of	io
hepatitis	hepatitis	nn1
C	c	zz1_np1
virus	virus	nn1
infection	infection	nn1
among	among	ii
inmates	inmate	nn2
entering	enter	vvg
the	the	at
California	california	np1
correctional	correctional	jj
system	system	nn1
.	.	y
The	the	at
Western	western	jj
Journal	journal	nn1
of	of	io
Medicine	medicine	nn1
,	,	y
170(3)		fo
,	,	y
156-160	156-160	mcmc
.	.	y
SAS	sa	np1
9.1	9.1	mc
2002-03	2002-03	mcmc
Cary	cary	np1
,	,	y
NC	nc	np1
,	,	y
USA	usa	np1
:	:	y
SAS	sa	np1
Institute	institute	nn1
Inc	inc	jj
.	.	y
Solomon	solomon	np1
,	,	y
L.	l	zz
,	,	y
Flynn	flynn	np1
,	,	y
C.	c	np1_zz1@
,	,	y
Muck	muck	nn1
,	,	y
K.	k	np1
,	,	y
&;		null
Vertefeuille	vertefeuille	np1
,	,	y
J.	xx_j	np1
2004	2004	mc
Prevalence	prevalence	nn1@_np1
of	of	io
HIV	hiv	np1
,	,	y
syphilis	syphilis	nn1
,	,	y
hepatitis	hepatitis	nn1
B	b	zz1
,	,	y
and	and	cc
hepatitis	hepatitis	nn1
C	c	zz1_np1
among	among	ii
entrants	entrant	nn2
to	to	ii
Maryland	maryland	np1
correctional	correctional	jj
facilities	facility	nn2
.	.	y
Journal	journal	nn1
of	of	io
Urban	urban	jj
Health	health	nn1
,	,	y
81(1)		fo
,	,	y
25-37	25-37	mcmc
.	.	y
Strathdee	strathdee	nn1_np1@
,	,	y
S.A.	sa	np1
,	,	y
&;		null
Sherman	sherman	np1
,	,	y
S.G.	sg	np1
2003	2003	mc
The	the	at
role	role	nn1
of	of	io
sexual	sexual	jj
transmission	transmission	nn1
of	of	io
HIV	hiv	np1
infection	infection	nn1
among	among	ii
injection	injection	nn1
and	and	cc
non-injection-drug	non-injection-drug	jj_nn1
users	user	nn2
.	.	y
Journal	journal	nn1
of	of	io
Urban	urban	jj
Health	health	nn1
,	,	y
80	80	nn1_vv0_jj
(	(	y
4	4	vv0_nn1_jj
,	,	y
Suppl.	suppl	np1
3	3	mc
)	)	y
,	,	y
iii7-iii14		nn1_jj
.	.	y
Thomas	thomas	np1
,	,	y
J.C.	j.c	np1
,	,	y
&;		null
Sampson	sampson	np1
,	,	y
L.A.	la	np1
2005	2005	mc
High	high	jj
rates	rate	nn2
of	of	io
incarceration	incarceration	nn1
as	as	ii_csa
a	a	at1
social	social	jj
force	force	nn1
associated	associate	vvn
with	with	iw
community	community	nn1
rates	rate	nn2
of	of	io
sexually	sexually	rr
transmitted	transmitted	jj_vvn
infection	infection	nn1
.	.	y
The	the	at
Journal	journal	nn1
of	of	io
Infectious	infectious	jj
Diseases	disease	nn2
,	,	y
191		nn1_vv0_jj
(	(	y
Suppl.	suppl	np1
1	1	mc1
)	)	y
,	,	y
S55-S60		nn1_jj
.	.	y
Vlahov	vlahov	np1
,	,	y
D.	d	np1
,	,	y
Nelson	nelson	np1
,	,	y
K.E.	ke	np1
,	,	y
Quinn	quinn	np1
,	,	y
T.C.	tc	np1
,	,	y
&;		null
Kendig	kendig	np1_vv0_nn1
,	,	y
N.	xx_n	np1_nnu
1993	1993	mc
Prevalence	prevalence	np1
and	and	cc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
in	in	ii
Maryland	maryland	np1
.	.	y
European	european	jj
Journal	journal	nn1
Epidemiology	epidemiology	nn1_np1
,	,	y
9(5)	9(5)	fo
,	,	y
566-569		mcmc
.	.	y
By	by	ii
William	william	np1
W.	w	np1
Latimer	latimer	np1
;	;	y
Sarra	sarra	np1
L.	l	zz
Hedden	hedden	np1_nn1
;	;	y
Leah	leah	np1
Floyd	floyd	np1
;	;	y
April	april	npm1_np1%
Lawson	lawson	np1
;	;	y
Alexander	alexander	np1
Melnikov	melnikov	np1
;	;	y
S.	s	zz
Geoffrey	geoffrey	np1
Severtson		np1
;	;	y
Anne-Gloria		np1
Moleko		np1_nn1
and	and	cc
Kristin	kristin	np1
Cole	cole	np1
Dr.	dr	nnb
Latimer	latimer	np1
,	,	y
Dr.	dr	nnb
Hedden	hedden	np1
,	,	y
Dr.	dr	nnb
Floyd	floyd	np1
,	,	y
Ms.	ms	nnb
Lawson	lawson	np1
,	,	y
Mr.	mr	nnb
Melnikov	melnikov	np1
and	and	cc
Mr.	mr	nnb
Severtson		np1
are	be	vbr
with	with	iw
the	the	at
Department	department	nn1
of	of	io
Mental	mental	jj
Health	health	nn1
,	,	y
Johns	john	np1
Hopkins	hopkins	np1
University	university	nn1
Bloomberg	bloomberg	np1
School	school	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
Baltimore	baltimore	np1
,	,	y
Maryland	maryland	np1
.	.	y
Dr.	dr	nnb
Anne-Gloria		np1
Moleko		np1_nn1
is	be	vbz
with	with	iw
the	the	at
Department	department	nn1
of	of	io
Human	human	jj_nn1
Sciences	science	nn2
,	,	y
University	university	nn1
of	of	io
Pretoria	pretoria	np1
,	,	y
Pretoria	pretoria	np1
,	,	y
South	south	np1
Africa	africa	np1
.	.	y
Kristin	kristin	np1@
Cole	cole	np1
,	,	y
M.S.W.	msw	np1
,	,	y
is	be	vbz
with	with	iw
the	the	at
Columbia	columbia	np1
University	university	nn1
School	school	nn1
of	of	io
Social	social	jj
Work	work	nn1
,	,	y
New	new	np1
York	york	np1
,	,	y
New	new	np1
York	york	np1
.	.	y
